Skip to main
BLLN

Billiontoone Inc (BLLN) Stock Forecast & Price Target

Billiontoone Inc (BLLN) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

BillionToOne Inc. has demonstrated significant financial progress, achieving a gross margin of 53.0% in 2024, a substantial increase from 24.1% the previous year, alongside impressive revenue growth of 117% year-over-year during its first quarter as a public company, culminating in a positive net income of $1.5 million. The company reported substantial gains in its prenatal and oncology segments, with revenue increases of 102% year-over-year for prenatal tests, totaling $74.1 million, and an impressive 664% growth in oncology revenue, reaching $8.7 million. Given the strong market demand and anticipated increases in tests per patient, BillionToOne is positioned for significant future growth, with the potential for a 25%+ revenue compound annual growth rate (CAGR) in reproductive health, indicating a robust financial outlook.

Bears say

The financial outlook for BillionToOne Inc appears concerning due to significant risks related to the protection of its proprietary technology, as any failure to maintain its competitive advantage could weaken its market position. Additionally, potential decreases in reimbursements from Medicare and Medicaid, especially under the Clarifying Lawful Overseas Use of Data (PAMA) rates, may adversely impact future revenue streams, further stressing the company's financial stability. Reports of increased denial rates from payers regarding the efficacy of their tests could hinder expected revenue growth, particularly in the core prenatal testing segment and new oncology tests, thereby casting doubt on profitability moving forward.

Billiontoone Inc (BLLN) has been analyzed by 6 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Billiontoone Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Billiontoone Inc (BLLN) Forecast

Analysts have given Billiontoone Inc (BLLN) a Buy based on their latest research and market trends.

According to 6 analysts, Billiontoone Inc (BLLN) has a Buy consensus rating as of Feb 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $137.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $137.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Billiontoone Inc (BLLN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.